CD7-CAR-T program
T-cell malignancies
Not specifiedDevelopment
Key Facts
About PersonGen BioTherapeutics
A Chinese biotech company developing next-generation CAR-T and allogeneic cellular therapies for T-cell cancers and autoimmune diseases.
View full company profileTherapeutic Areas
Other T-cell malignancies Drugs
| Drug | Company | Phase |
|---|---|---|
| Non-Gene Editing CAR | iCell Gene Therapeutics | Research/Preclinical |